Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8272)
All Articles published online
|
Jun 6, 2011 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fohl AL, Regal RE. Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all? World J Gastrointest Pharmacol Ther 2011; 2(3): 17-26 [PMID: 21731913 DOI: 10.4292/wjgpt.v2.i3.17] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v2/i3/17.htm |
| Number | Citing Articles |
| 1 |
Wilson Jose Mesquita, Craig M. Kline, Patricia Vernier, Anna M. Ledgerwood, Charles E. Lucas. Failure of gastric prophylaxis against stress bleeding reflects inadequate pH control. Surgery 2018; 164(4): 733 doi: 10.1016/j.surg.2018.05.019
|
| 2 |
Prävention der nosokomialen beatmungsassoziierten Pneumonie. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2013; 56(11): 1578 doi: 10.1007/s00103-013-1846-7
|
| 3 |
Clement L. Ren, Charles R. Esther, Jason S. Debley, Marianna Sockrider, Ozge Yilmaz, Nikhil Amin, Alia Bazzy-Asaad, Stephanie D. Davis, Manuel Durand, Jeffrey M. Ewig, Hasan Yuksel, Enrico Lombardi, Terry L. Noah, Peggy Radford, Sarath Ranganathan, Alejandro Teper, Miles Weinberger, Jan Brozek, Kevin C. Wilson. Official American Thoracic Society Clinical Practice Guidelines: Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing. American Journal of Respiratory and Critical Care Medicine 2016; 194(3): 356 doi: 10.1164/rccm.201604-0694ST
|
| 4 |
Su Xu, Ying Li, Xiaogang Xu, Jiachun Su, Demei Zhu, Fupin Hu, Minggui Wang. A Case-Control Study: Clinical Characteristics of Nosocomial Bloodstream Infections Versus Non-bloodstream Infections ofAcinetobacterspp.. Clinical Infectious Diseases 2018; 67(suppl_2): S189 doi: 10.1093/cid/ciy671
|
| 5 |
Martin Riegler, Sebastian F. Schoppman, Luigi Bonavina, David Ashton, Thomas Horbach, Matthias Kemen. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surgical Endoscopy 2015; 29(5): 1123 doi: 10.1007/s00464-014-3772-7
|
| 6 |
Sophia K. McKinley, Rebecca C. Dirks, Danielle Walsh, Celeste Hollands, Lauren E. Arthur, Noe Rodriguez, Joyce Jhang, Ahmed Abou-Setta, Aurora Pryor, Dimitrios Stefanidis, Bethany J. Slater. Surgical treatment of GERD: systematic review and meta-analysis. Surgical Endoscopy 2021; 35(8): 4095 doi: 10.1007/s00464-021-08358-5
|
| 7 |
Moloud Balafar, Morteza Ghojazadeh, Kavous Shahsavarinia, Zahra Parsian, Saba Hamedani, Hassan Soleimanpour. Association Between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis or Hepatic Encephalopathy in Cirrhotic Patients: A Systematic Review and Meta-analysis. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-132642
|
| 8 |
M. KRAG, A. PERNER, J. WETTERSLEV, M. H. MØLLER. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review. Acta Anaesthesiologica Scandinavica 2013; 57(7): 835 doi: 10.1111/aas.12099
|
| 9 |
Alice Wilkinson, Anousha Singal, Ghada Ramadan. Simple steps to prevent hospital-acquired pneumonia in non-intubated patients: a quality improvement project. British Journal of Nursing 2021; 30(2): 110 doi: 10.12968/bjon.2021.30.2.110
|
| 10 |
Marieke van Horck, Kim van de Kant, Bjorn Winkens, Geertjan Wesseling, Vincent Gulmans, Han Hendriks, Chris van der Grinten, Quirijn Jöbsis, Edward Dompeling. Risk factors for lung disease progression in children with cystic fibrosis. European Respiratory Journal 2018; 51(6): 1702509 doi: 10.1183/13993003.02509-2017
|
| 11 |
Meghana Sathe, Baha Moshiree, Enid Aliaj, MinJae Lee, Jessica Hudson, Alex Gifford, Susan Attel, Breck Gamel, Steven D. Freedman, Sarah Jane Schwarzenberg, A. Jay Freeman. Need to study simplification of gastrointestinal medication regimen in cystic fibrosis in the era of highly effective modulators. Pediatric Pulmonology 2023; 58(3): 811 doi: 10.1002/ppul.26257
|
| 12 |
Heather Baid. Patient Safety. Critical Care Nursing Clinics of North America 2016; 28(4): 451 doi: 10.1016/j.cnc.2016.07.005
|
| 13 |
Sandor Szabo. “Gastric cytoprotection” is still relevant. Journal of Gastroenterology and Hepatology 2014; 29(S4): 124 doi: 10.1111/jgh.12735
|
| 14 |
Marie C. Bradley, Tom Fahey, Caitriona Cahir, Kathleen Bennett, Dermot O’Reilly, Carole Parsons, Carmel M. Hughes. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. European Journal of Clinical Pharmacology 2012; 68(10): 1425 doi: 10.1007/s00228-012-1249-y
|
| 15 |
Manish S Bhatnagar, Sachin Choudhari, Dattatray Pawar, Akhilesh Sharma. Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle. Cureus 2024; doi: 10.7759/cureus.52773
|
| 16 |
Jieun Kang, Rugyeom Lee, Sei Won Lee. Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD. Respiratory Research 2023; 24(1) doi: 10.1186/s12931-023-02345-1
|
| 17 |
Kirk P. Conrad. Might proton pump or sodium‐hydrogen exchanger inhibitors be of value to ameliorate SARs‐CoV‐2 pathophysiology?. Physiological Reports 2021; 8(24) doi: 10.14814/phy2.14649
|
| 18 |
Taline A Boghossian, Farah Joy Rashid, Wade Thompson, Vivian Welch, Paul Moayyedi, Carlos Rojas-Fernandez, Kevin Pottie, Barbara Farrell. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database of Systematic Reviews 2017; 2017(3) doi: 10.1002/14651858.CD011969.pub2
|
| 19 |
Suraj Balakrishna, Aline Wolfensberger, Viacheslav Kachalov, Jan A Roth, Katharina Kusejko, Alexandra U Scherrer, Hansjakob Furrer, Christoph Hauser, Alexandra Calmy, Matthias Cavassini, Patrick Schmid, Enos Bernasconi, Manuel Battegay, Huldrych F Günthard, Roger D Kouyos, A Anagnostopoulos, M Battegay, E Bernasconi, J Böni, D L Braun, H C Bucher, A Calmy, M Cavassini, A Ciuffi, G Dollenmaier, M Egger, L Elzi, J Fehr, J Fellay, H Furrer, C A Fux, H Günthard, D Haerry, B Hasse, H H Hirsch, M Hoffmann, I Hösli, M Huber, C R Kahlert, L Kaiser, O Keiser, T Klimkait, R D Kouyos, H Kovari, B Ledergerber, G Martinetti, B Martinez de Tejada, C Marzolini, K J Metzner, N Müller, D Nicca, P Paioni, G Pantaleo, M Perreau, A Rauch, C Rudin, A U Scherrer, P Schmid, R Speck, M Stöckle, P Tarr, A Trkola, P Vernazza, G Wandeler, R Weber, S Yerly. Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study. The Journal of Infectious Diseases 2022; 225(9): 1592 doi: 10.1093/infdis/jiab573
|
| 20 |
Brandy McKelvy, Jennifer Cortes, Anabelle Keene. Infection Prevention in the Intensive Care Setting. 2024; : 77 doi: 10.1007/978-3-031-67062-6_6
|
| 21 |
Marina Milic, Anna Foster, Karim Rihawi, Alan Anthoney, Chris Twelves. ‘Tablet burden’ in patients with metastatic breast cancer. European Journal of Cancer 2016; 55: 1 doi: 10.1016/j.ejca.2015.11.015
|
| 22 |
How Do You Treat Gastroesophageal Reflux Disease in Your Practice?. Medical Acupuncture 2015; 27(4): 290 doi: 10.1089/acu.2015.29004.cpl
|
| 23 |
Søren Marker, Anders Perner, Jørn Wetterslev, Marija Barbateskovic, Janus Christian Jakobsen, Mette Krag, Anders Granholm, Carl Thomas Anthon, Morten Hylander Møller. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients—protocol for a systematic review with meta-analysis and trial sequential analysis. Systematic Reviews 2017; 6(1) doi: 10.1186/s13643-017-0509-4
|
| 24 |
|
| 25 |
Karin Sandoval, Ken Witt. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2015; 37: 433 doi: 10.1016/bs.seda.2015.05.008
|
| 26 |
Andrew C. Faust, Kelly L. Echevarria, Rebecca L. Attridge, Lyndsay Sheperd, Marcos I. Restrepo. Prophylactic Acid-Suppressive Therapy in Hospitalized Adults: Indications, Benefits, and Infectious Complications. Critical Care Nurse 2017; 37(3): 18 doi: 10.4037/ccn2017720
|
| 27 |
S. Valette, A. Dory, B. Gourieux, J.-C. Weber. Évaluation de l’implantation d’un processus de dé-prescription des inhibiteurs de la pompe à protons (IPP) à l’aide d’un algorithme au sein d’un service de médecine interne. La Revue de Médecine Interne 2021; 42(8): 535 doi: 10.1016/j.revmed.2020.11.014
|
| 28 |
Maria José Solana, Jesús López-Herce, Amelia Sánchez, César Sánchez, Javier Urbano, Dolores López, Angel Carrillo. 0.5 mg/kg versus 1 mg/kg of Intravenous Omeprazole for the Prophylaxis of Gastrointestinal Bleeding in Critically Ill Children: A Randomized Study. The Journal of Pediatrics 2013; 162(4): 776 doi: 10.1016/j.jpeds.2012.10.010
|
| 29 |
Dustin D. Linn, Robert D. Beckett, Kurtis Foellinger. Administration of enteral nutrition to adult patients in the prone position. Intensive and Critical Care Nursing 2015; 31(1): 38 doi: 10.1016/j.iccn.2014.07.002
|
| 30 |
|
| 31 |
|
| 32 |
Bilal A. Jalil, Karim El-Kersh. Enteral nutrition better than proton pump inhibitors?. Current Opinion in Critical Care 2019; 25(4): 334 doi: 10.1097/MCC.0000000000000620
|
| 33 |
Jing Miao, Sandra M Herrmann. Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis. Clinical Kidney Journal 2023; 16(11): 1834 doi: 10.1093/ckj/sfad109
|
| 34 |
Taline A Boghossian, Farah Joy Rashid, Vivian Welch, Carlos Rojas-Fernandez, Paul Moayyedi, Kevin Pottie, Kate Walsh, Lisa Pizzola, Wade Thompson, Barbara Farrell, Barbara Farrell. Cochrane Database of Systematic Reviews. 2015; doi: 10.1002/14651858.CD011969
|
| 35 |
Nilanka Wickramasinghe, Ahthavann Thuraisingham, Achini Jayalath, Dakshitha Wickramasinghe, Dharmabandhu N. Samarasekera, Etsuro Yazaki, Niranga Manjuri Devanarayana, Kenneth Vega. Gastroesophageal reflux disease in Sri Lanka: An island-wide epidemiological survey assessing the prevalence and associated factors. PLOS Global Public Health 2024; 4(5): e0003162 doi: 10.1371/journal.pgph.0003162
|
| 36 |
Peter Walentek. Xenopus epidermal and endodermal epithelia as models for mucociliary epithelial evolution, disease, and metaplasia. genesis 2021; 59(1-2) doi: 10.1002/dvg.23406
|
| 37 |
M. Barbateskovic, S. Marker, J. C. Jakobsen, M. Krag, A. Granholm, C. T. Anthon, A. Perner, J. Wetterslev, M. H. Møller. Stress ulcer prophylaxis in adult intensive care unit patients – a protocol for a systematic review. Acta Anaesthesiologica Scandinavica 2018; 62(6): 744 doi: 10.1111/aas.13109
|
| 38 |
Jui-Kun Chiang, Hsueh-Hsin Kao, Yee-Hsin Kao. Factors Associated with Hospitalized Community-Acquired Pneumonia among Elderly Patients Receiving Home-Based Care. Healthcare 2024; 12(4): 443 doi: 10.3390/healthcare12040443
|
| 39 |
Peter Walentek, Tina Beyer, Cathrin Hagenlocher, Christina Müller, Kerstin Feistel, Axel Schweickert, Richard M. Harland, Martin Blum. ATP4a is required for development and function of the Xenopus mucociliary epidermis – a potential model to study proton pump inhibitor-associated pneumonia. Developmental Biology 2015; 408(2): 292 doi: 10.1016/j.ydbio.2015.03.013
|
| 40 |
Marko Nemet, Marija Vukoja. Obstructive Sleep Apnea and Acute Lower Respiratory Tract Infections: A Narrative Literature Review. Antibiotics 2024; 13(6): 532 doi: 10.3390/antibiotics13060532
|
| 41 |
Adharsh Ravindran, Prasad G. Iyer. Geriatric Gastroenterology. 2021; : 1161 doi: 10.1007/978-3-030-30192-7_42
|
| 42 |
Properly prescribed, proton pump inhibitors are largely safe, but precautions are needed to prevent potential problems, overuse and misuse. Drugs & Therapy Perspectives 2019; 35(11): 550 doi: 10.1007/s40267-019-00671-3
|
| 43 |
Naina Mohamed Pakkir Maideen. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Medical Journal 2023; 59(2): 115 doi: 10.4068/cmj.2023.59.2.115
|
| 44 |
Jan Zirk‐Sadowski, Jane A. Masoli, Joao Delgado, Willie Hamilton, W. David Strain, William Henley, David Melzer, Alessandro Ble. Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults. Journal of the American Geriatrics Society 2018; 66(7): 1332 doi: 10.1111/jgs.15385
|
| 45 |
Stefan Niebisch, Fergal J. Fleming, Kelly M. Galey, Candice L. Wilshire, Carolyn E. Jones, Virginia R. Litle, Thomas J. Watson, Jeffrey H. Peters. Perioperative Risk of Laparoscopic Fundoplication: Safer than Previously Reported—Analysis of the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2009. Journal of the American College of Surgeons 2012; 215(1): 61 doi: 10.1016/j.jamcollsurg.2012.03.022
|
| 46 |
Adharsh Ravindran, Prasad G. Iyer. Geriatric Gastroenterology. 2020; : 1 doi: 10.1007/978-3-319-90761-1_42-1
|
| 47 |
Meng-Hsuan Lu, Hsueh-Chien Chiang. Turn over the new leaf of the treatment in peptic ulcer bleeding: a review of the literature. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241275318
|
| 48 |
Missale Solomon, James C. Reynolds. Geriatric Gastroenterology. 2012; : 311 doi: 10.1007/978-1-4419-1623-5_31
|
| 49 |
Allison A. Lambert, Jennifer O. Lam, Julie J. Paik, Cesar Ugarte-Gil, M. Bradley Drummond, Trevor A. Crowell, Abhishek Deshpande. Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis. PLOS ONE 2015; 10(6): e0128004 doi: 10.1371/journal.pone.0128004
|
| 50 |
Stefan Niebisch, Jeffrey H. Peters. Update on Fundoplication for the Treatment of GERD. Current Gastroenterology Reports 2012; 14(3): 189 doi: 10.1007/s11894-012-0256-6
|
| 51 |
Thevaraajan Jayaraman, Muhammad Ilham Abdul Hafidz, Nazri Mustaffa, Yeong Yeh Lee. Should I Be Concerned with the Long-Term Use of Proton Pump Inhibitor Therapy?. EMJ Gastroenterology 2016; : 74 doi: 10.33590/emjgastroenterol/10313088
|
| 52 |
Ronnell Regidor. H2RBs vs PPIs part 2: histamine-2 receptor blockers as a first-line agent for peptic ulcer disease prophylaxis. Gastrointestinal Nursing 2013; 11(6): 25 doi: 10.12968/gasn.2013.11.6.25
|
| 53 |
Bo Ram Yang, Jae‐Young Lee, Myeong Gyu Kim. The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid‐related diseases: An analysis of the national pharmacovigilance database in South Korea. Journal of Digestive Diseases 2022; 23(2): 118 doi: 10.1111/1751-2980.13075
|
| 54 |
Peter Malfertheiner, Arne Kandulski, Marino Venerito. Proton-pump inhibitors: understanding the complications and risks. Nature Reviews Gastroenterology & Hepatology 2017; 14(12): 697 doi: 10.1038/nrgastro.2017.117
|
| 55 |
Renata Rodriguez Imparato, Tereza Setsuko Toma. Proton pump inhibitor deprescription: A rapid review. Brazilian Journal of Pharmaceutical Sciences 2022; 58 doi: 10.1590/s2175-97902022e19989
|
| 56 |
Marie-Eve Rougé Bugat, M. Bourgouin, S. Gérard, S. Lozano, D. Brechemier, P. Cestac, C. Cool, L. Balardy. Drug prescription including interactions with anticancer treatments in the elderly: A global approach. The Journal of nutrition, health and aging 2017; 21(8): 849 doi: 10.1007/s12603-017-0946-8
|
| 57 |
Ronnell Regidor. Histamine-2 receptor blockers vs proton pump inhibitors part 1: a literature review. Gastrointestinal Nursing 2013; 11(5): 30 doi: 10.12968/gasn.2013.11.5.30
|
| 58 |
Linda J.T.M. van der Sande, Quirijn Jöbsis, Michiel A.G.E. Bannier, Ewoudt M.W. van de Garde, Jan J.M. Coremans, Frank de Vries, Edward Dompeling, Johanna H.M. Driessen. The risk of community-acquired pneumonia in children using gastric acid suppressants. European Respiratory Journal 2021; 58(4): 2003229 doi: 10.1183/13993003.03229-2020
|
| 59 |
Martine Marker Jensen, Søren Marker, Hien Quoc Do, Anders Perner, Morten Hylander Møller. Stress ulcer prophylaxis in critically ill children: Protocol for a systematic review. Acta Anaesthesiologica Scandinavica 2019; 63(7): 966 doi: 10.1111/aas.13361
|